Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14436
Articles
Company
Deals
BeiGene Reports Outstanding Q4 and Full-Year 2022 Financial Results
January 15, 2025
Company
Viatris Reports Q4 2022 Results, Highlights China Growth
January 15, 2025
Company
Medical Device
China Performs First AB-BNCT Procedures Outside Japan
January 15, 2025
Company
HutchMed Reports 2022 Financial Results with Revenue Growth
January 15, 2025
Company
Drug
3SBio’s Nalfurafine Tablets Accepted for Review by NMPA for Chronic Liver Disease
January 15, 2025
Company
Deals
3SBio Terminates Distribution Agreement with AstraZeneca for Byetta
January 15, 2025
Company
Drug
JW Therapeutics Initiates Clinical Study for JWATM214 in Advanced Hepatocellular Carcinoma
January 15, 2025
Company
FibroGen Reports Q4 2022 Financial Results with Revenue Growth
January 15, 2025
Policy / Regulatory
R&D
China Issues New Ethical Review Measures for Life Sciences and Medical Research
January 15, 2025
Company
Bayer Reports 2022 Sales Growth, Highlights New Drug Performances
January 15, 2025
Policy / Regulatory
China’s NRDL Update and Expansion of ‘Dual Channel’ Drug Access
January 15, 2025
Policy / Regulatory
China’s State Council Unveils Plan for TCM Revitalization and Development
January 15, 2025
1
2
…
1,021
1,022
1,023
1,024
1,025
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
